Bombesin receptors in a human duodenal tumor cell line: binding properties and function

B Y Williams1, A Schonbrunn

  • 1Department of Pharmacology, University of Texas Medical School, Houston 77225.

Cancer Research
|February 1, 1994
PubMed

Insights

This study identifies functional bombesin receptors in HuTu-80 duodenal cancer cells. These receptors activate signaling pathways but do not promote cell proliferation, offering insights into gastrointestinal tumor research.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Oncology

Background:

  • Bombesin peptides stimulate gut cell proliferation and are implicated in gastrointestinal tumors.
  • Limited cell line models exist for studying bombesin action in gastrointestinal cells.

Purpose of the Study:

  • To characterize functional bombesin receptors in the human duodenal cancer cell line, HuTu-80.
  • To investigate the role of bombesin receptors in HuTu-80 cell proliferation and growth.

Main Methods:

  • Radioligand binding assays using [125I-Tyr4]bombesin to determine receptor affinity and density.
  • Scatchard analysis to quantify binding sites.
  • Photoaffinity cross-linking to identify receptor molecular mass.
  • Measurement of inositol phosphate production and [3H]thymidine incorporation.

Main Results:

  • HuTu-80 cells possess high-affinity bombesin receptors (Kd = 80 +/- 20 pM) of the gastrin-releasing peptide (GRP) subtype.
  • Bombesin binding was inhibited by GRP and its analogs, with specific labeling of a 66 kDa protein.
  • Bombesin stimulated inositol phosphate production but did not affect [3H]thymidine incorporation or colony formation.

Conclusions:

  • HuTu-80 cells express functional, high-affinity GRP-subtype bombesin receptors.
  • These receptors are coupled to second messenger production but do not drive cell proliferation in this model.
  • This cell line serves as a valuable tool for studying bombesin receptor signaling independent of proliferative effects.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: